Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Tongzu He Ya Ri Xian Bai Er tablets
- Development stage
- Phase 2
- Lead developer
- Beijing University of Chinese Medicine
- Administration
- Oral
01
Overview
Tongzu He Ya Ri Xian Bai Er tablets (通阻合雅日仙白尔片 / 通阻合牙日仙拜尔片) is a traditional Uyghur medicine (herbal medicine) developed by Xinjiang Yinduolan Pharmaceutical and Beijing University of Chinese Medicine. It is formulated with multiple botanical ingredients, including Cassia fistula (清泻山扁豆/腊肠果), Operculina turpethum (盒果藤), Pimpinella anisum (茴芹果), Viola tianschanica (天山堇菜), Foeniculum vulgare (小茴香), Prunus dulcis (巴旦仁), and Citrullus colocynthis (药西瓜). The drug is being developed for the treatment of constipation, specifically the abnormal bile humor type in Uyghur medicine. It is currently in Phase II clinical development in China.
- Other names
- Tongzu He Ya Ri Xian Bai ErTongzu He Ya Ri Xian Bai Er Tablets通阻合牙日仙拜尔片通阻合牙日仙拜尔颗粒通阻合雅日仙白尔片
Beyond the preview
Go deeper on Tongzu He Ya Ri Xian Bai Er tablets.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Tongzu He Ya Ri Xian Bai Er tablets.